Prot# BHV4157-203: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of BHV-4157 in Patients with Mild to Moderate Alzheimer’s Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/18 → 9/30/22

Funding

  • University of California, San Diego (BHV4157 -203)
  • Biohaven Pharmaceuticals, Inc. (BHV4157 -203)